Modulation of cytotoxic amyloid fibrillation and mitochondrial damage of α-synuclein by catechols mediated conformational changes

Abstract

The interplay between α-synuclein (α-syn) and catechols plays a central role in Parkinson’s disease. This may be related to the modulating effects of catechols on the various aspects of α-syn fibrillization. Some of these effects may be attributed to the membrane-binding properties of the protein. In this work, we compare the effect of some catechols, including dopamine, epinephrine, DOPAL, and levodopa in micromolar concentrations, on the in vitro cytotoxicity of α-syn fibrils on human neuroblastoma SH-SY5Y cells. The study was followed by comparing the interactions of resulting structures with rat brain mitochondria used as an in vitro biological model. The obtained results demonstrate that catechols-induced structures have lost their cytotoxicity mimicking apoptotic cell death mediated by α-syn aggregates in different proportions. Moreover, α-syn fibrils-induced mitochondrial dysfunction, evaluated by a range of biochemical assays, was modulated by catechols-modified α-syn oligomers in different manners, as levodopa and DOPAL demonstrated the maximal and minimal effects, respectively. The plausible mechanism causing the inhibition of α-syn cytotoxic fibrillization and mitochondrial dysfunction by catechols is discussed. Taken together, we propose that catechols can prevent the cytotoxic assembly of α-syn and its destructive effects on mitochondria at various stages, suggesting that decreased levels of catechols in dopaminergic neurons might accelerate the α-syn cytotoxicity and mitochondrial dysfunction implicating Parkinson’s disease.

Recent advances and future directions of 3D to 6D printing in brain cancer treatment and neural tissue engineering

“…The field of neural tissue engineering is making rapid strides in its goal of repairing or replacing damaged tissues within the nervous system [19]. The potential of 3D printing technology lies in its remarkable capacity to produce intricate 3D structures with a high degree of precision and control.…”

Enhancing osteogenic differentiation of mesenchymal stem cells seeded on a polycaprolactone/MoS2 nanofibrous scaffold through electrical stimulation

“…Although bone possesses self-regeneration ability, in some cases, such as severe injury and substantial bone loss, difficult and costly treatments are necessary to repair the defect, posing a significant challenge in modern medicine. 1–4 The estimated treatment cost for osteoporosis-related fractures in Europe is projected to rise from 31.7 to 76.7 billion euros by 2050. 5 Previously, autografts have been recognized as the gold standard treatment, despite associated problems such as limited tissue supply, infection, immune rejection, and donor-site complications.…”